Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 6 | $4,321,918 |
| Sells | 13 | $430,539 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 27 Nov 2024 17:00 | SYRS | Syros Pharmaceuticals Inc | SIMONIAN NANCY A | Director | 25 Nov 2024 | Sale | 134,713 | 0.2653 | 35,739 | D |
| 20 Nov 2024 17:00 | SYRS | Syros Pharmaceuticals Inc | STEPHENS KRISTIN | Chief Development Officer | 18 Nov 2024 | Sale | 36,133 | 0.22 | 7,949 | D |
| 20 Nov 2024 17:00 | SYRS | Syros Pharmaceuticals Inc | ROTH DAVID | Chief Medical Officer | 18 Nov 2024 | Sale | 12,099 | 0.1969 | 2,382 | D |
| 20 Nov 2024 17:00 | SYRS | Syros Pharmaceuticals Inc | QUIRK GERALD E | Chief Legal & Compliance Offic | 19 Nov 2024 | Sale | 46,657 | 0.2212 | 10,321 | D |
| 20 Nov 2024 17:00 | SYRS | Syros Pharmaceuticals Inc | CHEE CONLEY | President & CEO | 18 Nov 2024 | Sale | 134,797 | 0.1998 | 26,932 | D |
| 20 Nov 2024 17:00 | SYRS | Syros Pharmaceuticals Inc | HAAS JASON | Chief Financial Officer | 18 Nov 2024 | Sale | 137,803 | 0.2103 | 28,980 | D |
| 12 Sep 2024 17:00 | SYRS | Syros Pharmaceuticals Inc | CHEE CONLEY | President & CEO | 10 Sep 2024 | Purchase | 50,000 | 1.5052 | 75,260 | D |
| 12 Sep 2024 17:00 | SYRS | Syros Pharmaceuticals Inc | CHEE CONLEY | President & CEO | 11 Sep 2024 | Purchase | 50,000 | 1.7084 | 85,420 | D |
| 12 Sep 2024 17:00 | SYRS | Syros Pharmaceuticals Inc | HAAS JASON | Chief Financial Officer | 12 Sep 2024 | Purchase | 45,344 | 1.6762 | 76,006 | D |
| 12 Sep 2024 17:00 | SYRS | Syros Pharmaceuticals Inc | HAAS JASON | Chief Financial Officer | 11 Sep 2024 | Purchase | 19,293 | 1.5781 | 30,446 | D |
| 12 Sep 2024 17:00 | SYRS | Syros Pharmaceuticals Inc | HAAS JASON | Chief Financial Officer | 10 Sep 2024 | Purchase | 35,363 | 1.5493 | 54,788 | D |
| 02 Jul 2024 16:15 | SYRS | Syros Pharmaceuticals Inc | YOUNG RICHARD A | Director | 28 Jun 2024 | Sale | 34,837 | 5.12 | 178,365 | D |
| 05 Apr 2024 16:30 | SYRS | Syros Pharmaceuticals Inc | ROTH DAVID | Chief Medical Officer | 03 Apr 2024 | Sale | 10,451 | 4.95 | 51,732 | D |
| 02 Apr 2024 16:58 | SYRS | Syros Pharmaceuticals Inc | ROTH DAVID | Chief Medical Officer | 02 Apr 2024 | Sale | 150 | 4.9803 | 747 | D |
| 26 Dec 2023 17:24 | SYRS | Syros Pharmaceuticals Inc | AKKARAJU SRINIVAS | Director | 21 Dec 2023 | Purchase | 904,977 | 4.42 | 3,999,998 | I |
| 14 Dec 2023 16:24 | SYRS | Syros Pharmaceuticals Inc | ROTH DAVID | Chief Medical Officer | 12 Dec 2023 | Sale | 6,287 | 4.95 | 31,121 | D |
| 08 Dec 2023 16:23 | SYRS | Syros Pharmaceuticals Inc | ROTH DAVID | Chief Medical Officer | 06 Dec 2023 | Sale | 6,287 | 3.95 | 24,834 | D |
| 02 Aug 2023 16:21 | SYRS | Syros Pharmaceuticals Inc | ROTH DAVID | Chief Medical Officer | 31 Jul 2023 | Sale | 7,348 | 3.95 | 29,025 | D |
| 18 Jul 2023 20:27 | SYRS | Syros Pharmaceuticals Inc | OLSON ERIC R | Chief Scientific Officer | 17 Jul 2023 | Sale | 689 | 3.5 | 2,412 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)